Sami Alasfar, M.D., M.P.H.

  1. Nephrologist
  1. Hommos MS, Brown A, Trollinger B, Sekkarie M, Alasfar S. Do not forget about transplant patients during disasters. Curr Opin Nephrol Hypertens. 2024 Nov 1; 33 (6):627-635 Epub 2024 Sept 12
    View PubMed
  2. Alasfar S, Koubar SH, Gautam SC, Jaar BG. Kidney Care in Times of Crises: A Review. Am J Kidney Dis. 2024 Nov; 84 (5):621-631 Epub 2024 June 06
    View PubMed
  3. Sekkarie M, Murad L, Alasfar S. Assessment of the response to kidney patients' needs in disaster-stricken Syria. Curr Opin Nephrol Hypertens. 2024 Nov 1; 33 (6):621-626 Epub 2024 June 20
    View PubMed
  4. Alasfar S, Me HM, Budhiraja P. Approach to Late Noninfectious Post-Transplant Complications. Adv Kidney Dis Health. 2024 Sep; 31 (5):436-449
    View PubMed
  5. Abdo N, Mohamed S, Luyckx V, Mohammad A, Rahman SAE, Christine K, Alexander J, Khaled HN, Lina M, Oussama RA, Alasfar S, Ahmad A. Metal phosphide poisoning in a disaster-stricken area. Can early hemodialysis improve outcomes? Hemodial Int. 2024 Jul; 28 (3):351-357 Epub 2024 June 27
    View PubMed
  6. Alasfar S, Alashavi H, Nasan KH, Haj Mousa AA, Polinori C, Luyckx V, Sekkarie M, Kaysi S, Murad L, Burnham GM. Providing Hemodialysis in Unstable Areas: An Assessment and Framework for Effective Care. Kidney Int Rep. 2024 Mar; 9 (3):580-588 Epub 2023 Dec 20
    View PubMed
  7. Luyckx VA, Alasfar S, Bajpai D, Atwater CE, Knight J, Talbot B, Davies S, Niang A. Providing environmentally sustainable nephrology care: focus in low- and middle-income countries. Kidney Int. 2024 Feb; 105(2):259-268. Epub 2023 Nov 25.
    View PubMed
  8. Alasfar S, Berhe E, Karam S, Luyckx V. Impact of persistent conflict and destabilizing events on dialysis care. Nat Rev Nephrol. 2023 Nov; 19 (11):688-689
    View PubMed
  9. Alasfar S, Zakaria W, Nasan KH, Zanabli AR, Al-Saghir F, Rifai AO, Luyckx V, Murad L, Kaysi S, Al-Makki A, Sekkarie M. Dealing with dramatic health care problems during times of natural disaster and armed conflict. Kidney Int. 2023 Aug; 104 (2):221-224 Epub 2023 May 13
    View PubMed
  10. Alasfar S, Kodali L, Schinstock CA. Current Therapies in Kidney Transplant Rejection. J Clin Med. 2023 Jul 27; 12 (15) Epub 2023 July 27
    View PubMed
  11. Alasfar S, Alashavi H, Nasan KH, Haj Mousa AA, Alkhatib I, Kazancioglu R, Sekkarie M, Kaysi S, Daher M, Murad L, Burnham GM. Improving and maintaining quality of hemodialysis in areas affected by war: a call to action! Kidney Int 2023 May; 103 (5):817-820
    View PubMed
  12. Mejia C, Tariq A, Alotaibi M, Lakhani L, Greenspan W, Naqvi F, Alasfar S, Brennan DC. Prospective Assessment of the Prevalence of Enter Hyperoxalosis in Kidney Transplant Candidates. Transplant Direct. 2023 Apr; 9 (4):e1464 Epub 2023 Mar 29
    View PubMed
  13. Burnham GM, Alashavi H, Alasfar S. Quality improvement methods to strengthen hemodialysis in Northwest Syria J Glob Health Sci. 2023; 4(2):16.
  14. Liu C, Alasfar S, Reese PP, Mohan S, Doshi MD, Hall IE, Thiessen Philbrook H, Jia Y, Stewart D, Parikh CR. Trends in the procurement and discard of kidneys from deceased donors with acute kidney injury. Am J Transplant. 2022 Mar; 22(3):898-908. Epub 2021 Dec 22.
    View PubMed
  15. Sait AS, Chiang TP, Marr KA, Massie AB, Cochran W, Shah P, Brennan DC, Thomas AG, Mehta Steinke S, Permpalung N, Shoham S, Merlo C, Jain T, Boyarsky B, Charnaya O, Gurakar A, Sharma K, Durand CM, Werbel WA, Huang CY, Ostrander D, Desai N, Kim MY, Alasfar S, Bloch EM, Tobian AAR, Garonzik-Wang J, Segev DL, Avery RK. Outcomes of SOT Recipients With COVID-19 in Different Eras of COVID-19 Therapeutics. Transplant Direct. 2022 Jan; 8 (1):e1268 Epub 2021 Dec 23
    View PubMed
  16. Malik RF, Jia Y, Mansour SG, Reese PP, Hall IE, Alasfar S, Doshi MD, Akalin E, Bromberg JS, Harhay MN, Mohan S, Muthukumar T, Schroppel B, Singh P, Weng FL, Thiessen Philbrook HR, Parikh CR. Post-transplant Diabetes Mellitus in Kidney Transplant Recipients: A Multicenter Study. Kidney360. 2021 Aug 26; 2 (8):1296-1307 Epub 2021 June 02
    View PubMed
  17. Abuzeineh M, Kyeso Y, Philogene MC, Alachkar N, Alasfar S. Presentation and Outcomes of Antibody-Mediated Rejection Associated With Angiotensin II Receptor 1 Antibodies Among Kidney Transplant Recipients. Transplant Proc. 2021 Jun; 53 (5):1501-1508 Epub 2021 Feb 09
    View PubMed
  18. Kyeso Y, Bhalla A, Smith AP, Jia Y, Alakhdhair S, Ogir SC, Abuzeineh M, Brennan DC, Alasfar S. Donor-derived Cell-free DNA Kinetics Post-kidney Transplant Biopsy. Transplant Direct. 2021 Jun; 7 (6):e703 Epub 2021 May 25
    View PubMed
  19. Lakhani L, Alasfar S, Bhalla A, Aala A, Rosenberg A, Ostrander D, Schollenberger MD, Brennan DC, Lipson EJ. Utility of Serial Donor-derived Cell-free DNA Measurements for Detecting Allograft Rejection in a Kidney Transplant Recipient After PD-1 Checkpoint Inhibitor Administration. Transplant Direct. 2021 Feb; 7 (2):e656 Epub 2021 Jan 15
    View PubMed
  20. Alasfar S, Hall IE, Mansour SG, Jia Y, Thiessen-Philbrook HR, Weng FL, Singh P, Schroppel B, Muthukumar T, Mohan S, Malik RF, Harhay MN, Doshi MD, Akalin E, Bromberg JS, Brennan DC, Reese PP, Parikh CR. Contemporary incidence and risk factors of post transplant Erythrocytosis in deceased donor kidney transplantation. BMC Nephrol. 2021 Jan 12; 22 (1):26
    View PubMed
  21. Abuzeineh M, Desai N, Brennan DC, Alasfar S. COVID-19 Early After a Deceased Donor Kidney Transplant Surgery. Transplantation 2020 Dec; 104 (12):e354-e355
    View PubMed
  22. Alasfar S, Avery RK. The impact of COVID-19 on kidney transplantation. Nat Rev Nephrol. 2020 Oct; 16 (10):568-569
    View PubMed
  23. Abuzeineh M, Aala A, Alasfar S, Alachkar N. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria. BMC Nephrol. 2020 Jul 2; 21 (1):253 Epub 2020 July 02
    View PubMed
  24. Alasfar S, Isreb M, Kaysi S, Hatahet K. Renal Transplantation in Areas of Armed Conflict. Semin Nephrol. 2020 Jul; 40 (4):386-392
    View PubMed
  25. Concepcion BP, Alasfar S, Levea SL, Singh P, Wiseman A. The Transplant Nephrology Workforce in the United States: Current State and Future Directions. Adv Chronic Kidney Dis. 2020 Jul; 27 (4):336-343.e1 Epub 2020 Oct 24
    View PubMed
  26. Kant S, Bhalla A, Alasfar S, Alachkar N. Ten-year outcome of Eculizumab in kidney transplant recipients with atypical hemolytic uremic syndrome- a single center experience. BMC Nephrol. 2020 May 20; 21 (1):189
    View PubMed
  27. Bhalla A, Alachkar N, Alasfar S. Complement-Based Therapy in the Management of Antibody-Mediated Rejection. Adv Chronic Kidney Dis. 2020 Mar; 27 (2):138-148
    View PubMed
  28. Alhamad T, Manllo Dieck J, Younus U, Matar D, Alasfar S, Vujjini V, Wall D, Kanawati B, Reiser J, Brennan DC, Alachkar N. ACTH Gel in Resistant Focal Segmental Glomerulosclerosis After Kidney Transplantation. Transplantation. 2019 Jan; 103 (1):202-209
    View PubMed
  29. Alachkar N, Li J, Matar D, Vujjini V, Alasfar S, Tracy M, Reiser J, Wei C. Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab. BMC Nephrol. 2018 Dec 17; 19 (1):361
    View PubMed
  30. Philogene MC, Zhou S, Lonze BE, Bagnasco S, Alasfar S, Montgomery RA, Kraus E, Jackson AM, Leffell MS, Zachary AA. Pre-transplant Screening for Non-HLA Antibodies: Who should be Tested? Hum Immunol. 2018 Apr; 79 (4):195-202 Epub 2018 Feb 08
    View PubMed
  31. Alasfar S, Matar D, Montgomery RA, Desai N, Lonze B, Vujjini V, Estrella MM, Manllo Dieck J, Khneizer G, Sever S, Reiser J, Alachkar N. Rituximab and Therapeutic Plasma Exchange in Recurrent Focal Segmental Glomerulosclerosis Postkidney Transplantation. Transplantation. 2018 Mar; 102 (3):e115-e120
    View PubMed
  32. McMahon BA, Koyner JL, Novick T, Menez S, Moran RA, Lonze BE, Desai N, Alasfar S, Borja M, Merritt WT, Ariyo P, Chawla LS, Kraus E. The prognostic value of the furosemide stress test in predicting delayed graft function following deceased donor kidney transplantation. Biomarkers. 2018 Feb; 23 (1):61-69 Epub 2017 Oct 16
    View PubMed
  33. Menez S, Hruskova Z, Scott J, Cormican S, Chen M, Salama AD, Alasfar S, Little MA, Safrankova H, Honsova E, Tesar V, Geetha D. Predictors of Renal Outcomes in Sclerotic Class Anti-Neutrophil Cytoplasmic Antibody Glomerulonephritis. Am J Nephrol. 2018; 48 (6):465-471 Epub 2018 Nov 23
    View PubMed
  34. Alachkar H, Mutonga M, Kato T, Kalluri S, Kakuta Y, Uemura M, Imamura R, Nonomura N, Vujjini V, Alasfar S, Rabb H, Nakamura Y, Alachkar N. Quantitative characterization of T-cell repertoire and biomarkers in kidney transplant rejection. BMC Nephrol. 2016 Nov 21; 17 (1):181
    View PubMed
  35. Nijim S, Vujjini V, Alasfar S, Luo X, Orandi B, Delp C, Desai NM, Montgomery RA, Lonze BE, Alachkar N. Recurrent IgA Nephropathy After Kidney Transplantation. Transplant Proc. 2016 Oct; 48 (8):2689-2694
    View PubMed
  36. Alasfar S, Carter-Monroe N, Rosenberg AZ, Montgomery RA, Alachkar N. Membranoproliferative glomerulonephritis recurrence after kidney transplantation: using the new classification. BMC Nephrol. 2016 Jan 11; 17:7
    View PubMed
  37. Alasfar S, Alachkar N. Atypical hemolytic uremic syndrome post-kidney transplantation: two case reports and review of the literature. Front Med (Lausanne). 2014; 1:52 Epub 2014 Dec 12
    View PubMed
  38. Alkhouli M, Alasfar S, Samuels LA. Valvular heart disease and dialysis access: a case of cardiac decompensation after fistula creation. J Vasc Access 2013 Jan-Mar; 14 (1):96 Epub 2012 July 26
    View PubMed